Merck & Co. Stock Surges Near Record Highs Amid Analyst Support

Merck & Co., Inc.'s stock has reached near-record highs following an impressive year-to-date performance of 38.76 percent, with shares trading around $143.87 as of September 14, 2026.

The company's stock price is still below its average analyst target of $152.96, indicating a potential upside of about 6 percent, according to data from Moomoo.

Merck & Co.'s upcoming dividend payment on October 7, 2026, with an ex-dividend date of September 15, 2026, is also expected to provide near-term support for the stock.

Analysts have been bullish on Merck & Co., with a strong majority recommending 'Strong Buy' or 'Buy' ratings, which may continue to drive the company's stock price upwards in the coming weeks and months.